Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Venous thromboembolism in a general hospital. An update with low molecular weight heparin prophylaxis.

Venous thromboembolism in a general hospital. An update with low molecular weight heparin prophylaxis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Venous thromboembolism in a general hospital. An update with low molecular weight heparin prophylaxis. Abstract Text:

    s l schulzS L Schulz,c kesselringC Kesselring,u seebergerU Seeberger,d andresenD Andresen,

    BACKGROUND: Patients admitted to hospital for surgery or acute medical illnesses have a high risk for venous thromboembolism (VTE). Today's widespread use of low molecular weight heparins (LMWH) for VTE prophylaxis is supposed to have reduced VTE rates substantially. However, data concerning the overall effectiveness of LMWH prophylaxis is sparse. PATIENTS AND METHODS: We prospectively studied all patients with symptomatic and objectively confirmed VTE seen in our hospital over a three year period. Event rates in different wards were analysed and compared. VTE prophylaxis with Enoxaparin was given to all patients at risk during their hospital stay. RESULTS: A total of 50 464 inpatients were treated during the study period. 461 examinations were carried out for symptoms suggestive of VTE and yielded 89 positive results in 85 patients. Seventy eight patients were found to have deep vein thrombosis, 7 had pulmonary embolism, and 4 had both deep venous thrombosis and pulmonary embolism. The overall in hospital VTE event rate was 0.17%. The rate decreased during the study period from 0.22 in year one to 0,16 in year two and 0.13 % in year three. It ranged highest in neurologic and trauma patients (0.32%) and lowest (0.08%) in gynecology-obstetrics. CONCLUSIONS: With a simple and strictly applied regimen of prophylaxis with LMWH the overall rate of symptomatic VTE was very low in our hospitalized patients. Beside LMWH prophylaxis, shortening hospital stays and substantial improvements in surgical and anesthesia techniques achieved during the last decades probably play an essential role in decreasing VTE rates.

    Venous thromboembolism in a general hospital. An update with low molecular weight heparin prophylaxis. Publishing Authors By Initials

    sl schulzSL Schulz,c kesselringC Kesselring,u seebergerU Seeberger,d andresenD Andresen,

    For similar cardiovascular diseases: vascular diseases: embolism and thrombosis: thrombosis: venous thrombosis research abstracts see: cardiovascular diseases: vascular diseases: embolism and thrombosis: thrombosis: venous thrombosis research

    PUBMED ID PMID:

    MEDLINE DATE:

    Venous thromboembolism in a general hospital. An update with low molecular weight heparin prophylaxis. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: VASA. Zeitschrift für Gefässkrankheiten. Journal f

    VOLUME: 36

    Page Numbers: 17-22

    Journal Abbreviation: VASA

    ISSN: 0301-1526

    DAY: 13

    MONTH: Feb

    YEAR: 2007

    Venous thromboembolism in a general hospital. An update with low molecular weight heparin prophylaxis. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 317051

    Venous thromboembolism in a general hospital. An update with low molecular weight heparin prophylaxis. Keywords Mesh Terms:

    KEYWORDS: Venous Thrombosis

    MESH TERMS: ultrasonography

    Chemical & Substance for Abstract: Venous thromboembolism in a general hospital. An update with low molecular weight heparin prophylaxis. Information

    Substance Name: Enoxaparin

    Registry Number: 0

    Grant and Affiliation Information for Venous thromboembolism in a general hospital. An update with low molecular weight heparin prophylaxis.

    AFFILIATION: Vivantes Klinikum Am Urban Berlin, Germany. susanne.schulz@vivantes.de

    Country: Switzerland

    Switzerland Research PublicationSwitzerland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Vasa

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Venous thromboembolism in a general hospital An update with low molecular weight heparin prophylaxis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News